Tang Junyi, Li Wencan, Jiang Fanli, Wang Tao
Department of Thoracic and Cardiovascular Surgery, The Affiliated Zhuzhou Hospital Xiangya Medical College CSU, 116 Changjiangnan Road, Zhuzhou, 412007, Hunan, China.
J Cardiothorac Surg. 2020 Dec 17;15(1):335. doi: 10.1186/s13019-020-01376-9.
A newly infectious diseases named coronavirus disease 2019 (COVID-19) emerged in China and now has spread in many countries, and constituted a public health emergency of international concern. Extracorporeal membrane oxygenation (ECMO) is used as salvage therapies in critical COVID-19 patients with respiratory/cardiac failure.
A 49-year-old female patient was diagnosed with COVID-19 and progressed to critical cases, she was successfully treated with the application of awake extracorporeal membrane oxygenation. This case is the first reported successfully treatment of application awake ECMO in critical COVID-19 patient in China.
Here we present the first reported successfully treatment of application awake ECMO in critical COVID-19 patient, however, whether awake ECMO can be widely used in the treatment of critical COVID-19 patients need more practice.
一种名为2019冠状病毒病（COVID-19）的新型传染病在中国出现，现已在许多国家传播，并构成了国际关注的突发公共卫生事件。体外膜肺氧合（ECMO）被用作治疗呼吸/心力衰竭的重症COVID-19患者的挽救疗法。
一名49岁女性患者被诊断为COVID-19并进展为重症病例，通过应用清醒体外膜肺氧合成功治愈。该病例是中国首例报道的应用清醒ECMO成功治疗重症COVID-19患者的案例。
在此，我们首次报道了应用清醒ECMO成功治疗重症COVID-19患者的案例，然而，清醒ECMO能否广泛应用于治疗重症COVID-19患者还需要更多实践。
